BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4047275)

  • 1. Impaired metabolism of guanidinoacetic acid in uremia.
    Tofuku Y; Muramoto H; Kuroda M; Takeda R
    Nephron; 1985; 41(2):174-8. PubMed ID: 4047275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on impaired metabolism of guanidinoacetic acid in chronic renal failure rabbits with special reference to impaired conversion of arginine to guanidinoacetic acid.
    Kuroda M
    Nephron; 1993; 65(4):605-11. PubMed ID: 8302418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Study of impaired metabolism of guanidinoacetic acid in uremia--the compensatory role of the pancreas in guanidinoacetic acid synthesis].
    Hirata M
    Nihon Jinzo Gakkai Shi; 1989 Sep; 31(9):951-61. PubMed ID: 2685430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelation of urinary and plasma levels of guanidinoacetic acid with alteration in renal activity of glycine amidinotransferase in acute renal failure rats.
    Kuwagaki Y; Sudo J
    Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):781-4. PubMed ID: 2752493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of 72% injury in one kidney on several organs involved in guanidino compound metabolism: a time course study.
    Levillain O; Marescau B; Possemiers I; Al Banchaabouchi M; De Deyn PP
    Pflugers Arch; 2001 Jul; 442(4):558-69. PubMed ID: 11510889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Guanidino compounds in the elderly].
    Matsumura M; Kuroda M; Itoh M; Hatakeyama S; Haruki K; Hirata M; Koni I; Takeda R; Tofuku Y
    Nihon Ronen Igakkai Zasshi; 1992 Apr; 29(4):279-84. PubMed ID: 1614007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guanidino compound metabolism in rats subjected to 20% to 90% nephrectomy.
    Levillain O; Marescau B; de Deyn PP
    Kidney Int; 1995 Feb; 47(2):464-72. PubMed ID: 7536856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biosynthesis of guanidinoacetic acid in isolated rat tubules].
    Takeda M
    Nihon Jinzo Gakkai Shi; 1990 Feb; 32(2):117-26. PubMed ID: 2352355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A study of guanidine metabolism in uremia, with special reference to serum guanidinoacetic acid in anephric patients].
    Tofuku Y; Kuroda M; Muramoto H; Takeda R
    Nihon Jinzo Gakkai Shi; 1984 Feb; 26(2):171-81. PubMed ID: 6748335
    [No Abstract]   [Full Text] [Related]  

  • 10. [Platelet aggregation in chronic renal failure--whole blood aggregation and effect of guanidino compounds].
    Maejima M; Takahashi S; Hatano M
    Nihon Jinzo Gakkai Shi; 1991 Feb; 33(2):201-12. PubMed ID: 2051648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors affecting serum and urinary guanidinosuccinic acid levels in normal and uremic subjects.
    Kopple JD; Gordon SI; Wang M; Swendseid ME
    J Lab Clin Med; 1977 Aug; 90(2):303-11. PubMed ID: 886215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.
    Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP
    Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolism of guanidinoacetic acid and creatine in uremia].
    Muramoto H
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):117-28. PubMed ID: 3386016
    [No Abstract]   [Full Text] [Related]  

  • 14. Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis.
    De Deyn P; Marescau B; Lornoy W; Becaus I; Van Leuven I; Van Gorp L; Lowenthal A
    Nephron; 1987; 45(4):291-5. PubMed ID: 3587469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guanidino compounds and aliphatic monoamines in acute and chronic renal failure].
    Suzuki Y
    Nihon Jinzo Gakkai Shi; 1992 Oct; 34(10):1077-85. PubMed ID: 1289608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds.
    Eloot S; Torremans A; De Smet R; Marescau B; De Wachter D; De Deyn PP; Lameire N; Verdonck P; Vanholder R
    Kidney Int; 2005 Apr; 67(4):1566-75. PubMed ID: 15780113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effect of partial nephrectomy on biological parameters, kidney histology, and guanidino compound levels in mice.
    Al Banchaabouchi M; Marescau B; Van Marck E; D'hooge R; De Deyn PP
    Metabolism; 2001 Dec; 50(12):1418-25. PubMed ID: 11735086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impaired metabolism of guanidinoacetic acid in uremia, with special reference to diabetic nephropathy].
    Hirata M; Muramoto H; Haruki K; Tofuku Y; Takeda R
    Nihon Jinzo Gakkai Shi; 1988 Feb; 30(2):129-36. PubMed ID: 3386017
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma concentration and urinary excretion of guanidine derivatives in normal subjects and patients with renal failure.
    Sawynok J; Dawborn JK
    Clin Exp Pharmacol Physiol; 1975; 2(1):1-15. PubMed ID: 1126056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum guanidino compound levels in uremic pediatric patients treated with hemodialysis or continuous cycle peritoneal dialysis. Correlations between nerve conduction velocities and altered guanidino compound concentrations.
    De Deyn PP; Robitaille P; Vanasse M; Qureshi IA; Marescau B
    Nephron; 1995; 69(4):411-7. PubMed ID: 7777105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.